الصفحة الرئيسية>>Signaling Pathways>> Antibody-drug Conjugate/ADC Related>> ADC Linker>>Fmoc-NH-PEG8-CH2COOH

Fmoc-NH-PEG8-CH2COOH

رقم الكتالوجGC64814

Fmoc-NH-PEG8-CH2COOH هو رابط ADC قابل للانقسام يستخدم في تخليق اتحادات الأجسام المضادة والأدوية (ADCs)Fmoc-NH-PEG8-CH2COOH هو أيضًا رابط PROTAC قائم على PEG ويمكن استخدامه في تركيب PROTACs

Products are for research use only. Not for human use. We do not sell to patients.

Fmoc-NH-PEG8-CH2COOH التركيب الكيميائي

Cas No.: 868594-52-9

الحجم السعر المخزون الكميّة
25 mg
54٫00
متوفر
50 mg
81٫00
متوفر
100 mg
135٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Fmoc-NH-PEG8-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG8-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

[1]. Michael A, et al. Synthesis of Bifunctional Integrin‐Binding Peptides Containing PEG Spacers of Defined Length for Non‐Viral Gene Delivery. Volume2008, Issue17.

مراجعات

Review for Fmoc-NH-PEG8-CH2COOH

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Fmoc-NH-PEG8-CH2COOH

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.